Bliss GVS Pharma Ltd

NSE: BLISSGVS · BSE: 506197 · Pharmaceuticals & Biotechnology · 40 announcements

Share price: ₹681.55
Market cap: ₹7,247 Cr
Revenue (annual): ₹927.1 Cr
Net profit (annual): ₹129.1 Cr
P/E (TTM): 53.2×Sector 47.3×
Promoter holding: 35.01%-0.35% QoQ
FII holding: 8.07%Current quarter

Reference market data from a third-party provider, updated daily. Not a valuation or a recommendation.

Announcement type

All Open Offer 7 Employee Stock Options 7 Annual General Meeting 6 Other Announcement 3 Management Change 3 Financial Results 3 Board Meeting Date 3 Promoter Selling 2 Capital Structure Change 2 Credit Rating 1 Business Update 1 Acquisition 1

Time

All time Last 1 week Last 1 month Last 2 months Last 3 months Last 6 months Last 1 year

1 announcement with these filters

8 Apr 2026 16:11 IST NSE

Credit Rating

Bliss GVS Pharma Credit Rating

Bliss GVS Pharma Limited has been assigned a credit rating of [ICRA]A- (Stable) and [ICRA]A2+ by ICRA Limited for its bank facilities worth ₹100.00 Crore. This rating reflects the company's creditworthiness and stable financial outlook for its fund-based and non-fund-based instruments.

Value: ₹100.0 Cr

Read the filing ↗